This underlines the dilemma of modern imaging with 68Ga-PSMA PET/CT, which so far has a superior detection of relapses than any other imaging modality for prostate cancer but is still not sensitive enough for the low PSA levels associated with the highest chance of long-term BRFS after sRT. Here, KLK3 is linked to prostate cancer.